The FDA Is About to Deal With CBD—and Wants to Hear From You
In the News: Shared from Leafly
Cannabidiol, or CBD, has become wildly popular in recent years—and widely available, both online and in stores across the country. But despite the belief by some that the 2018 farm bill broadly legalized the cannabinoid, the truth is that federal agencies are still scrambling to determine their next steps.
Want a say in the process? Now’s your chance.
The US Food and Drug Administration oversees the nation’s food, pharmaceutical drugs, and cosmetics—three categories of products that have recently been overwhelmed by CBD and various claims about its benefits. As the FDA begins to craft regulations around CBD and infused products, the agency is asking for public comment on how to proceed.
“While the use of cannabis and cannabis-derived products, including hemp and hemp-derived products, has increased dramatically in recent years, questions remain regarding the safety considerations raised by the widespread use of these products,” wrote Lowell Schiller, the FDA’s acting associate commissioner for policy…